| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.24B | +6.4% | +11.9% |
| Cost of Revenue | $1.11B | +2.3% | -6.5% |
| Gross Profit | $1.13B | +10.7% | +38.9% |
| R&D Expense | $180.0M | +4.7% | +11.1% |
| SG&A Expense | $478.0M | +0.0% | +1.9% |
| Operating Income | $530.0M | +21.8% | +29.9% |
| Pre-tax Income | $440.0M | +28.7% | +47.2% |
| Income Tax | $89.0M | +122.5% | +74.5% |
| Net Income | $350.0M | +14.8% | +38.9% |
| EPS (Basic) | $3.11 | +14.8% | +40.1% |
| EPS (Diluted) | $3.10 | +15.2% | +39.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $423.0M | -4.7% | -6.0% |
| Accounts Receivable | $1.88B | +6.2% | +3.5% |
| Inventory | $1.23B | +0.6% | +4.3% |
| Current Assets | $4.08B | +2.4% | +8.4% |
| Total Assets | $11.26B | +0.2% | +2.4% |
| Current Liabilities | $3.75B | +8.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $554.0M | +136.8% | — |
| Capital Expenditures | $109.0M | +70.3% | — |
| Investing Cash Flow | -$119.0M | -72.5% | — |
| Financing Cash Flow | -$436.0M | -185.0% | — |
| Free Cash Flow | $445.0M | +161.8% | — |
| +4.5% |
| Long-term Debt | $2.57B | -0.1% | +0.1% |
| Stockholders' Equity | $3.52B | -6.0% | +2.4% |